Provenienza dei contatti di primo grado di Helle Haxgart
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Helle Haxgart tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MALIN CORPORATION PLC | Biotechnology | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
International N&H Denmark ApS
International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Director/Board Member | |
GENMAB A/S | Pharmaceuticals: Major | Chairman | |
PHOTOCURE ASA | Medical Specialties | Director/Board Member | |
BIOPORTO A/S | Medical Specialties | Director/Board Member | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
University of Aarhus | College/University | Corporate Officer/Principal | |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
Technical University of Denmark | College/University | Graduate Degree | |
University of Copenhagen | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
University of Southern Denmark | College/University | Masters Business Admin | |
Danmarks Farmaceutiske Universitet | College/University | Undergraduate Degree | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
DTU Systems Biology | Director/Board Member | ||
SERODUS ASA | Biotechnology | Chief Executive Officer | |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries PolyPeptide Laboratories A/S manufactures polypeptides and custom peptide synthesis. It offers custom research grade, good manufacturing practice-grade, therapeutic, generic and radiolabeled peptides. The company was founded in 2004 and is headquartered in Hillerod, Denmark. | Chemicals: Specialty | Corporate Officer/Principal | |
The Danish National Advanced Technology Foundation
The Danish National Advanced Technology Foundation Financial ConglomeratesFinance The Danish National Advanced Technology Foundation promotes research and innovation by providing funds. It offers private companies and universities the funds and the framework for developing new and important technologies. The company was founded in 2005 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
William Demant Fonden | Investment Trusts/Mutual Funds | Director/Board Member | |
Phlogo ApS
Phlogo ApS Pharmaceuticals: MajorHealth Technology Part of Serodus ASA, Phlogo ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The company is based in Hellerup, Denmark. Phlogo was acquired by Serodus ASA on July 10, 2013. | Pharmaceuticals: Major | Chairman | |
AVT Business School A/S | College/University | Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin | |
CURASIGHT A/S | Medical Specialties | Director/Board Member | |
The Danish Green Growth Fund | Investment Trusts/Mutual Funds | Director/Board Member | |
Danish Medical Research Council | Corporate Officer/Principal | ||
Antag Therapeutics ApS
Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
Vjack Holding Ivs
Vjack Holding Ivs Financial ConglomeratesFinance Vjack Holding Ivs functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Sea Longevity ApS | Director/Board Member | ||
Vitaminpack Ivs | Director/Board Member | ||
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Pharmaceuticals: Major | Chairman | |
Lyhne & Co. | Director/Board Member | ||
AMNIOTICS AB | Biotechnology | Corporate Officer/Principal | |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Danimarca | 30 |
Norvegia | 5 |
Stati Uniti | 3 |
Svezia | 3 |
Germania | 2 |
Settori
Health Technology | 22 |
Consumer Services | 8 |
Finance | 4 |
Miscellaneous | 3 |
Consumer Non-Durables | 2 |
Posizioni
Director/Board Member | 22 |
Corporate Officer/Principal | 16 |
Independent Dir/Board Member | 6 |
Chairman | 5 |
Chief Executive Officer | 4 |
Contatti più connessi
Insiders | |
---|---|
Kirsten Drejer | 18 |
Eva Steiness | 12 |
Rasmus Just | 7 |
Helle Størum | 6 |
Ivan M. Møller | 6 |
Kirsten Dreyer | 1 |
- Borsa valori
- Insiders
- Helle Haxgart
- Connessioni Società